by GlobeNewsWire | Jan 25, 2016 | Globe Newswire, GNW Alerts
GAITHERSBURG, Md., Jan. 25, 2016 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that it intends to...